Search
Research
Upskilling Service Providers on LGBTQA+ Suicide PreventionThis project aims to implement LGBTQA+ youth suicide prevention guidelines in clinical and community services in Western Australia.
Research
Exploring LGBTQA+ young people’s experiences of suicidality: a qualitative studyPenelope Helen Yael Strauss Morgan Perry BA, MPH, PhD BA (Hons), Doctor of Psychology BPsych (Hons) MPsych (Clin) PhD Research Fellow in Youth
Research
Virtual Reality Integrated Social Recovery (VISOR)As well as specific symptom clusters, psychosis effects important non-symptom domains including social cognition and social-occupational functioning.
Research
Suicide prevention in LGBTQA+ young people: Best practice guidelines for clinical and community service providersThese guidelines outline a set of best practices for suicide prevention in LGBTQA+ young people, targeting both clinical and community service providers.
Research
LGBTQIA+ Inclusive Practice Training for Medical and Psychology StudentsThis research aims to improve the mental health of LGBTQIA+ individuals through enhanced inclusive practice training for trainee health professionals.
Research
The Cardiovascular Risk Evaluation in Expectant Fathers (CARE-Dads) StudySusan Prescott MBBS BMedSci PhD FRACP Honorary Research Fellow susan.prescott@thekids.org.au Honorary Research Fellow Susan Prescott is a Professor
Research
Vulnerable from the first breath - epithelial dysfunction and respiratory outcomes in childrenWe have been studying the importance of the epithelial cells lining the airways in the nose and lungs.
Research
A Phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK's meningococcal Group B and combined ABCWY vaccines when administered to healthy adolescents and young adults (Quintet)Jennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
A randomized, controlled, observer-blind, phase 1/2a study to evaluate the safety, reactogenicity, and immunogenicity of Ad26.RSV.preF in RSV-seronegative toddlers 12 to 24 months of ageJennifer Peter Kent Richmond RN MBBS MRCP(UK) FRACP Clinical Research Manager Head, Vaccine Trials Group Jennifer.Kent@thekids.org.au Clinical
Research
Acute viral bronchiolitis in infants and young childrenAnya Deborah Pat Jones Strickland Holt BSc MSc PhD PhD PhD, DSc, FRCPath, FRCPI, FAA Honorary Research Associate Head, Pregnancy and Early Life